The government of Russia’s capital Moscow city, together with private investors will invest about 10 billion roubles ($137 million) in the construction of at least three large-scale pharmaceutical enterprises, which will produce more than 110 drugs for the city's needs within the next several years, according to recent statements by the Deputy Mayor of Moscow for Economic Policy and Land and Property Relations Vladimir Efimov.
Building of the factories will be carried as part of offset contracts signed with investors, reports The Pharma Letter’s local correspondent.
According to Mr Efimov, the annual purchases of drugs from these factories by the Moscow city will reach 33.5 billion roubles ($463 million).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze